MRI-Guided Cryoablation for Focal Native Prostate Cancer
About this study
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.
- Condition
- Primary Malignant Neoplasm of Prostate (Diagnosis)
- Tested
- MR guided cryoablation
- Sponsor
- Mayo Clinic
Who can join
- Age
- 30 to 100 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 30 years
- Maximum age: 100 years
- Eligible sex: Male
- Study condition: Primary Malignant Neoplasm of Prostate (Diagnosis)
- Patients with "biopsy proven" Gleason7 prostate cancer referred to Urology and/or Interventional Radiology for treatment
- Surgery and/or Radiation is not a desirable alternative therapy at the time of enrollment
- Tumor size is \< 2 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Patient is able to undergo MRI
Where
1 site, 1 recruiting
Mayo Clinic
Rochester, Minnesota, United States
Contact
-
Desirae Howe-Clayton
507-255-0111 howe.desirae@mayo.edu
Potential match only. Final eligibility is determined by the study team.